National Institute for Health and Care Excellence, Weight Management: Lifestyle Services for Overweight or Obese Results. Public Health Guideline, National Institute for Health and Care Excellence, London, UK, May 2014.

In the next step, the weight loss and weight maintenance efficacy of IQP-AE-103 should be evaluated in longer clinical trials. Also, it would be worthwhile to further investigate any positive effect on cardiovascular risk factors associated with obesity, particularly in subjects with elevated blood lipids. For further elucidation of mode of action, an assessment of fecal fat excretion, or postprandial blood lipid changes and potentially gut microbiome study could be considered. 5. Conclusion and Implication Hunger Buddy must be taken as a whole capsule with a full glass of water (approximately 250ml). Do not open the capsule and avoid taking it in powder form to avoid choking. U. Bongartz, et al., “Double-blind, Randomized, Placebo-Controlled, Bicentric Clinical Investigation to Evaluate the Benefit and Tolerability of Redusure IQP-AK-102 in Reducing Body Weight in Overweight and Obese Subjects,” Advancement in Medicinal Plant Research 4(3), 73–82 (2016).

Figure 3: Tanitol 14-week placebo-controlled, randomised, double-blind clinical trial results Weight loss through increased satiety Clinically proven efficacy: Promote weight loss through a reduced food consumption - prevent unnecessary snaking and hunger pangs

Redusure™, a proprietary blend of high-swelling capacity dietary fibres, potassium bicarbonate, microcrystalline cellulose, magnesium stearate. For beneficial action of fibres on gastrointestinal transit, it is recommended to drink at least 2L of water a day. Slight constipation could occur in case of limited liquid intake. If constipation persists despite adequate fluid intake, please consult your healthcare professional. Figure 2: Litramine 14-week placebo-controlled, randomised, double-blind clinical trial results Weight loss through digestive enzyme inhibition B. Grube, et al., “A Natural Fiber Complex Reduces Body Weight in the Overweight and Obese: A Double-Blind, Randomized, Placebo-Controlled Study,” Obesity 21, 58–64 (2013).As an intellectual property attorney, I understand how important it is to have high quality legal representation for protecting valuable brand names. No significant differences in changes of feeling of fullness and food cravings between the study arms were observed. However, feeling of hunger decreased in 66% of subjects in the high-dose group (statistically significant pre-post change). This may be related to the swelling property of okra pods reported earlier [ 22]. Okra constituents such as soluble fibre or polysaccharides may increase viscosity of taken meal and form a gel, thus increasing gastric distension and thereby promoting satiety [ 45]. This research confirms Redusure's role in appetite reduction by promoting pleasant feelings of fullness when taken before meals,' stated Holly Tully, VP of Marketing, InQpharm NA. 'The study also reveals just how effective these appetite-reducing properties are in helping individuals lose weight at a consistent, healthy rate.' Proprietary ingredient clinically shown to increase satiety and support significant weight loss in overweight and obese adults

Plants have always been a good source of new potential and natural therapies for illnesses, including body weight management products. Litramine®, a natural fibre complex derived from Opuntia ficus-indica, enriched with soluble fibres from Acacia sp., has been shown in a number of clinical trials to safely and effectively reduce and maintain weight loss [ 17– 20]. Litramine® has been demonstrated to reduce dietary fat absorption and increase fecal fat excretion, resulting in lower calorie absorption from diet, which leads to weight loss [ 20, 21]. XLS Medical Hunger Buddy belongs to a clinically proven and innovative range of weight management products scientifically developed for a healthier and balanced life No, you don’t need to head to your computer to compress a PDF file. With PDF2Go you can do this - you guessed it - on the go. InQpharm’s Redusure is a patent-pending fibre complex based on glucomannan, carrageenan and xanthan gum. Designed to work like an impermanent, natural lap band, Redusure swells in the stomach, filling up to 43% of the volume, helping individuals to feel fuller for longer. Weight management treatments range from natural, oral solutions to risky, invasive surgical procedures. In the dietary supplement industry, new products constantly offer promises to dieters; yet, most are born from similar technology and mechanisms of action.

Stool frequency was assessed based on bowel movements recorded in the subject diaries 3 days a week. Physical activity was recorded using validated International Physical Activity Questionnaire, Short Form (IPAQ-SF) [ 36] during all study visits from visit 2 to visit 6. That is why I chose to have Trademark Elite to register the trademark for my award-winning law blog. Don't take this product if you are allergic to sulphur-containing products (such as sulfites) or any of the ingredients listed. If you experience any allergic symptoms, such as skin rashes or difficulty in breathing or any other side effects, please consult your doctor immediately. D. S. Kumar, D. E. Tony, A. P. Kumar, K. A. Kumar, D. B. S. Rao, and R. Nadendla, “A review on Abelmoschus esculentus (okra),” International Research Journal of Pharmaceutical and Applied Sciences, vol. 3, no. 4, pp. 129–132, 2013.View at: Google Scholar

In addition, a combination of dehydrated okra pod powder and inulin, the active ingredients in IQP-AE-103, has been shown to be a strong fat-binding agent in an in vitro setting simulating in vivo conditions (data not shown); it also exerts high swelling capacity and significantly enhances solution viscosity. Thus, IQP-AE-103 appears to be a promising natural agent that may help to control calorie intake, decrease absorption of dietary fat, and consequently lead to body weight reduction. Dietetic and pharmaceutical preparations for the treatment of metabolic syndrome and related diseases namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia and obesity, general weight management, treatment of obesity and prevention of obesity; chemical preparations for medical and pharmaceutical purposes for the treatment of metabolic syndrome and related diseases for the treatment of metabolic syndrome and related diseases namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia and obesity, general weight management, treatment of obesity and prevention of obesity; dietary supplement for humans for general health and wellbeing; pharmaceutical and nutraceutical preparations primarily of plant extracts adapted for dietetic use for the treatment and prevention of metabolic syndrome and related diseases, namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia, anemia, bulimia nervosa, anorexia and obesity, general weight management, treatment of obesity and prevention of obesity; pharmaceutical and nutraceutical preparations primarily of plant extracts adapted for medical use for the treatment and prevention of metabolic syndrome and related diseases, namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia, anemia, bulimia nervosa, anorexia and obesity, general weight management, treatment of obesity and prevention of obesity; pharmaceutical and nutraceutical preparations primarily of plant extracts adapted for nutritional use for the treatment and prevention of metabolic syndrome and related diseases, namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia, anemia, bulimia nervosa, anorexia and obesity, general weight management, treatment of obesity and prevention of obesity; pharmaceutical and nutraceutical preparations primarily of plant extracts adapted for pharmaceutical use for the treatment and prevention of metabolic syndrome and related diseases, namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia, anemia, bulimia nervosa, anorexia and obesity, general weight management, treatment of obesity and prevention of obesity; plant extracts adapted for the treatment of metabolic syndrome and related diseases for the treatment and prevention of metabolic syndrome and related diseases, namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia, anemia, bulimia nervosa, anorexia and obesity, general weight management, treatment of obesity and prevention of obesity, general weight management, treatment of obesity, prevention of obesity and blood glucose management; medicated food supplements for the treatment of metabolic syndrome and related diseases, namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia, anemia, bulimia nervosa, anorexia and obesity, general weight management, treatment of obesity and prevention of obesity, general weight management, treatment of obesity and prevention of obesity; weight management supplements; nutritional food additives for medical purposes in the nature of food extracts derived from plant extracts, for the treatment of metabolic syndrome and related diseases, namely, diabetes, hypoglycaemia, hypertension, heart diseases, cardiovascular diseases, hyperlipidaemia, hypercholesterolemia, anemia, bulimia nervosa, anorexia and obesity, general weight management, treatment of obesity and prevention of obesity; plant extracts for medical use namely extract of Amorphophallus konjac; nutritional supplements to reduce, control appetite; nutritional supAs food exits the stomach more slowly, the complex may delay the intestine’s absorption of glucose, helping to reduce the appetite and sustain feelings of satiety. The REDUSURE trademark was assigned an Application Number # 1756268 by the Canadian Intellectual Property Office (CIPO).